-+ 0.00%
-+ 0.00%
-+ 0.00%

SCYNEXIS Says On March 15, 2026 Co Received FDA Orphan Drug Designation For Brexafemme (Triterpenoid Antifungal) For Treatment Of Invasive Candidiasis

Benzinga·03/16/2026 16:18:01
Listen to the news